Summary
- Current Price
- As of today, ATTO price is $22.79, up +1.15% on
- Current Price All-Time High
- ATTO price is currently -18.61% below its historical high of $28.00 set on
- Market Cap
- ATTO current market cap is $1B
- Revenue
- ATTO current annual revenue is $1.35M, up +100.00% year-over-year
- Next Earnings
- The next earnings release for ATTO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Attovia Therapeutics, Inc. |
| Ticker | NASDAQ: ATTO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | attovia.com |
| Employees | 44 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $22.79 | |
| Price, 1D Change | +1.15% | |
| $1B | ||
| - | ||
| - | ||
| 2.66 | ||
| $1.35M | ||
| Revenue, 1Y Change | +100.00% | |
| -$1.33 | ||
| EPS, 1Y Change | -35.20% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.33 | ||
| EPS Estimate | -$3.45 | |
| EPS Est. Change | -158.62% | |
| $1.35M | ||
| Revenue Estimate | $450.00K | |
| Revenue Est. Change | -66.67% | |
| Current Price | $22.79 | |
| Price Target | $45.00 | - |
| Price Tgt. Change | +97.46% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.99 | - | |
| - | -$1.33 | - | |
| -$3.45 | N/A | -158.62% | |
| -$2.38 | N/A | -78.41% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $1.35M | - | |
| $450.00K | N/A | -66.67% | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $22.79 | |
| $21.37 | ||
| $21.37 | ||
| - | ||
| - | ||
| $1.15 | ||
| 2.66 | ||
| $2.19 | ||
| 53.76 | ||
| 69.56% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $1.35M | ||
| -$1.33 | ||
| $546.00K | ||
| 40.44% | ||
| -$67.16M | ||
| -4,974.74% | ||
| -$60.90M | ||
| -4,510.96% | ||
| -$66.36M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.03 | ||
| 14.20 | ||
| 14.20 | ||
| - | ||
| - | ||
| 40.12 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 2,311.98 | ||
| -7.15 | ||
| -22.52 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$107.44M | ||
| $152.27M | ||
| $165.89M | ||
| $156.30M | ||
| $15.10M | ||
| $11.01M | ||
| $5.26M | ||
| $1.92M | ||
| $3.55M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $62.25M | ||
| $67.71M | ||
| $804.00K | ||
| $14.36M | ||
| $804.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$59.20M | ||
| -$73.46M | ||
| $142.01M | ||
| $2.31M | ||
| -$61.51M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| RBC Capital | ||
| Morgan Stanley | ||
| LifeSci Capital | ||
| Leerink Partners | ||
| Citigroup |
Analyst sentiment
Institutional ownership
No data
Screeners with ATTO
FAQ
- What is the ticker symbol for Attovia Therapeutics, Inc.?
- The ticker symbol for Attovia Therapeutics, Inc. is NASDAQ:ATTO
- Does Attovia Therapeutics, Inc. pay dividends?
- No, Attovia Therapeutics, Inc. does not pay dividends
- What sector is Attovia Therapeutics, Inc. in?
- Attovia Therapeutics, Inc. is in the Healthcare sector
- What industry is Attovia Therapeutics, Inc. in?
- Attovia Therapeutics, Inc. is in the Biotechnology industry
- What country is Attovia Therapeutics, Inc. based in?
- Attovia Therapeutics, Inc. is headquartered in United States
- When did Attovia Therapeutics, Inc. go public?
- Attovia Therapeutics, Inc. initial public offering (IPO) was on August 5, 2026
- Is Attovia Therapeutics, Inc. in the S&P 500?
- No, Attovia Therapeutics, Inc. is not included in the S&P 500 index
- Is Attovia Therapeutics, Inc. in the NASDAQ 100?
- No, Attovia Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Attovia Therapeutics, Inc. in the Dow Jones?
- No, Attovia Therapeutics, Inc. is not included in the Dow Jones index
- When does Attovia Therapeutics, Inc. report earnings?
- The next expected earnings date for Attovia Therapeutics, Inc. is November 11, 2026
Data Sources & References
- ATTO Official Website www.attovia.com
- ATTO Profile on Yahoo Finance finance.yahoo.com/quote/ATTO
- ATTO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/atto